サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1376505

冠動脈バイパスグラフトの市場：方法、手技、製品別-2023-2030年の世界予測

Coronary Artery Bypass Grafts Market by Method (Minimally Invasive Direct CABG, Off-Pump, On-Pump), Procedure (Double CABG Surgery, Quadruple CABG Surgery, Single CABG Surgery), Product - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 183 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
冠動脈バイパスグラフトの市場：方法、手技、製品別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

冠動脈バイパスグラフト市場は、2022年の161億3,000万米ドルから2030年には260億5,000万米ドルに達すると予測され、予測期間中のCAGRは6.17%です。

冠動脈バイパスグラフトの世界市場

主な市場の統計
市場金額：基準年[2022] 161億3,000万米ドル
推定市場金額[2023] 171億1,000万米ドル
予測市場金額[2030] 260億5,000万米ドル
CAGR（%） 6.17%
冠動脈バイパスグラフト Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは冠動脈バイパスグラフト市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.冠動脈バイパスグラフト市場の市場規模および予測は？

2.冠動脈バイパスグラフト市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.冠動脈バイパスグラフト市場における競争戦略の窓とは？

4.冠動脈バイパスグラフト市場の最新技術動向と規制の枠組みは？

5.冠動脈バイパスグラフト市場における主要ベンダーの市場シェアは？

6.冠動脈バイパスグラフト市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 冠動脈疾患の有病率の増加
      • ヘルスケア費の増加と心臓専門センターの数の増加
      • CABG手術に対する有利な償還ポリシー
    • 抑制要因
      • CABG手術の合併症とリスクに関する懸念
    • 機会
      • ロボット支援手術などの低侵襲CABG技術の開発
      • 手術手技と画像技術の進歩
    • 課題
      • 冠動脈疾患を予防するための代替技術の利用可能性
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 冠動脈バイパスグラフトの市場：方法別

  • 低侵襲直接CABG
  • オフポンプ
  • オンポンプ

第7章 冠動脈バイパスグラフトの市場手順別

  • 二重CABG手術
  • 四重CABG手術
  • 単回CABG手術
  • トリプルCABG手術

第8章 冠動脈バイパスグラフトの市場：製品別

  • 胃大網動脈
  • 内胸動脈グラフト
  • 橈骨動脈
  • 伏在静脈グラフト

第9章 南北アメリカの冠動脈バイパスグラフトの市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の冠動脈バイパスグラフトの市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの冠動脈バイパスグラフトの市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AtriCure, Inc.
    • Boston Scientific Corporation
    • Edwards Lifesciences
    • enVVeno Medical Corporation
    • Genesee Biomedical Inc.
    • Getinge AB
    • KARL STORZ SE & Co. KG
    • Medtronic PLC
    • Peters Surgical
    • Scanlan International, Inc.
    • Stryker Corporation
    • Teleflex Incorporated
    • Terumo Corporation
    • Transonic Systems Inc.
    • Vascular Graft Solutions Ltd.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CORONARY ARTERY BYPASS GRAFTS MARKET RESEARCH PROCESS
  • FIGURE 2. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. CORONARY ARTERY BYPASS GRAFTS MARKET DYNAMICS
  • FIGURE 7. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
  • FIGURE 8. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2022 VS 2030 (%)
  • FIGURE 10. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 12. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY BYPASS GRAFTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 6. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE DIRECT CABG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF-PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ON-PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 10. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY DOUBLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY QUADRUPLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY TRIPLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GASTROEPIPLOIC ARTERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY INTERNAL THORACIC ARTERY GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY RADIAL ARTERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SAPHENOUS VEIN GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 147. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 148. CORONARY ARTERY BYPASS GRAFTS MARKET LICENSE & PRICING
目次
Product Code: MRR-2A0283E255CE

The Coronary Artery Bypass Grafts Market is projected to reach USD 26.05 billion by 2030 from USD 16.13 billion in 2022, at a CAGR of 6.17% during the forecast period.

Global Coronary Artery Bypass Grafts Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 16.13 billion
Estimated Year Value [2023] USD 17.11 billion
Forecast Year Value [2030] USD 26.05 billion
CAGR (%) 6.17%
Coronary Artery Bypass Grafts Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Coronary Artery Bypass Grafts Market.

Based on Method, market is studied across Minimally Invasive Direct CABG, Off-Pump, and On-Pump. The On-Pump is projected to witness significant market share during forecast period.

Based on Procedure, market is studied across Double CABG Surgery, Quadruple CABG Surgery, Single CABG Surgery, and Triple CABG Surgery. The Quadruple CABG Surgery is projected to witness significant market share during forecast period.

Based on Product, market is studied across Gastroepiploic Artery, Internal Thoracic Artery Grafts, Radial Artery, and Saphenous Vein Grafts. The Radial Artery is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Coronary Artery Bypass Grafts Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Coronary Artery Bypass Grafts Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Coronary Artery Bypass Grafts Market, highlighting leading vendors and their innovative profiles. These include AtriCure, Inc., Boston Scientific Corporation, Edwards Lifesciences, enVVeno Medical Corporation, Genesee Biomedical Inc., Getinge AB, KARL STORZ SE & Co. KG, Medtronic PLC, Peters Surgical, Scanlan International, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Transonic Systems Inc., and Vascular Graft Solutions Ltd..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Coronary Artery Bypass Grafts Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Coronary Artery Bypass Grafts Market?

3. What is the competitive strategic window for identifying opportunities in the Coronary Artery Bypass Grafts Market?

4. What are the latest technology trends and regulatory frameworks in the Coronary Artery Bypass Grafts Market?

5. What is the market share of the leading vendors in the Coronary Artery Bypass Grafts Market?

6. Which modes and strategic moves are suitable for entering the Coronary Artery Bypass Grafts Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Coronary Artery Bypass Grafts Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of coronary artery diseases
      • 5.1.1.2. Rising healthcare expenditure and growing number of cardiac specialty centers
      • 5.1.1.3. Favorable reimbursement policies for CABG surgery
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with complications and risk of CABG surgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of minimally invasive CABG techniques such as robotic-assisted surgery
      • 5.1.3.2. Advancements in surgical techniques and imaging technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternate technologies for prevention of coronary artery diseases
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Coronary Artery Bypass Grafts Market, by Method

  • 6.1. Introduction
  • 6.2. Minimally Invasive Direct CABG
  • 6.3. Off-Pump
  • 6.4. On-Pump

7. Coronary Artery Bypass Grafts Market, by Procedure

  • 7.1. Introduction
  • 7.2. Double CABG Surgery
  • 7.3. Quadruple CABG Surgery
  • 7.4. Single CABG Surgery
  • 7.5. Triple CABG Surgery

8. Coronary Artery Bypass Grafts Market, by Product

  • 8.1. Introduction
  • 8.2. Gastroepiploic Artery
  • 8.3. Internal Thoracic Artery Grafts
  • 8.4. Radial Artery
  • 8.5. Saphenous Vein Grafts

9. Americas Coronary Artery Bypass Grafts Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Coronary Artery Bypass Grafts Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Coronary Artery Bypass Grafts Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. AtriCure, Inc.
    • 13.1.2. Boston Scientific Corporation
    • 13.1.3. Edwards Lifesciences
    • 13.1.4. enVVeno Medical Corporation
    • 13.1.5. Genesee Biomedical Inc.
    • 13.1.6. Getinge AB
    • 13.1.7. KARL STORZ SE & Co. KG
    • 13.1.8. Medtronic PLC
    • 13.1.9. Peters Surgical
    • 13.1.10. Scanlan International, Inc.
    • 13.1.11. Stryker Corporation
    • 13.1.12. Teleflex Incorporated
    • 13.1.13. Terumo Corporation
    • 13.1.14. Transonic Systems Inc.
    • 13.1.15. Vascular Graft Solutions Ltd.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing